Tower Research Capital (TRC)’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.5K | Buy |
7,797
+5,781
| +287% | +$20K | ﹤0.01% | 3531 |
|
|
2025
Q4 | $10.4K | Sell |
2,016
-2,186
| -52% | -$10.6K | ﹤0.01% | 3774 |
|
|
2025
Q3 | $17.7K | Sell |
4,202
-19,453
| -82% | -$90.4K | ﹤0.01% | 3416 |
|
|
2025
Q2 | $86.6K | Buy |
23,655
+20,228
| +590% | +$75.4K | ﹤0.01% | 2501 |
|
|
2025
Q1 | $14.8K | Buy |
3,427
+3,003
| +708% | +$12.1K | ﹤0.01% | 3262 |
|
|
2024
Q4 | $1.36K | Sell |
424
-7,597
| -95% | -$25.5K | ﹤0.01% | 5037 |
|
|
2024
Q3 | $22.9K | Sell |
8,021
-1,530
| -16% | -$4.29K | ﹤0.01% | 3167 |
|
|
2024
Q2 | $26.7K | Buy |
9,551
+8,880
| +1,323% | +$23.8K | ﹤0.01% | 3570 |
|
|
2024
Q1 | $1.91K | Sell |
671
-5,992
| -90% | -$20.4K | ﹤0.01% | 5159 |
|
|
2023
Q4 | $27.3K | Buy |
6,663
+3,235
| +94% | +$9.06K | ﹤0.01% | 3473 |
|
|
2023
Q3 | $10.9K | Sell |
3,428
-1,490
| -30% | -$4.74K | ﹤0.01% | 4063 |
|
|
2023
Q2 | $16.3K | Buy |
4,918
+868
| +21% | +$2.56K | ﹤0.01% | 3568 |
|
|
2023
Q1 | $9K | Sell |
4,050
-3,973
| -50% | -$9.81K | ﹤0.01% | 4523 |
|
|
2022
Q4 | $22K | Sell |
8,023
-75,296
| -90% | -$220K | ﹤0.01% | 3052 |
|
|
2022
Q3 | $270K | Buy |
83,319
+19,823
| +31% | +$89.6K | ﹤0.01% | 1644 |
|
|
2022
Q2 | $310K | Buy |
63,496
+16,024
| +34% | +$98.6K | 0.01% | 1456 |
|
|
2022
Q1 | $362K | Buy |
47,472
+21,083
| +80% | +$163K | ﹤0.01% | 1349 |
|
|
2021
Q4 | $244K | Buy |
26,389
+5,968
| +29% | +$63.4K | ﹤0.01% | 1612 |
|
|
2021
Q3 | $291K | Buy |
20,421
+13,954
| +216% | +$217K | 0.01% | 1442 |
|
|
2021
Q2 | $108K | Buy |
6,467
+3,758
| +139% | +$70.1K | ﹤0.01% | 2362 |
|
|
2021
Q1 | $49K | Buy |
2,709
+619
| +30% | +$8.39K | ﹤0.01% | 3148 |
|
|
2020
Q4 | $16K | Sell |
2,090
-19,430
| -90% | -$92.3K | ﹤0.01% | 4011 |
|
|
2020
Q3 | $82K | Buy |
21,520
+16,303
| +312% | +$64.4K | ﹤0.01% | 3297 |
|
|
2020
Q2 | $20K | Buy |
+5,217
| New | +$18.8K | ﹤0.01% | 3682 |
|
|
2020
Q1 | – | Sell |
-12,034
| Closed | -$58K | – | 3651 |
|
|
2019
Q4 | $58K | Buy |
+12,034
| New | +$76.3K | ﹤0.01% | 1244 |
|
|
2019
Q3 | – | Sell |
-1,133
| Closed | -$9K | – | 4400 |
|
|
2019
Q2 | $9K | Buy |
+1,133
| New | +$8.33K | ﹤0.01% | 2622 |
|
|
2018
Q4 | – | Sell |
-2,575
| Closed | -$26K | – | 4203 |
|
|
2018
Q3 | $26K | Sell |
2,575
-2,695
| -51% | -$27.2K | ﹤0.01% | 2169 |
|
|
2018
Q2 | $53K | Buy |
5,270
+1,245
| +31% | +$12.5K | ﹤0.01% | 1825 |
|
|
2018
Q1 | $40K | Buy |
4,025
+1,997
| +98% | +$19.9K | ﹤0.01% | 1795 |
|
|
2017
Q4 | $20K | Buy |
2,028
+852
| +72% | +$8.46K | ﹤0.01% | 2072 |
|
|
2017
Q3 | $12K | Buy |
+1,176
| New | +$11.7K | ﹤0.01% | 2993 |
|
Other funds holding ORGO
SCM
FLAM
VCM
Tower Research Capital (TRC)'s ORGO Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Organogenesis Holdings (ORGO) stake by 287% in Q1 2026, buying an estimated $20K and bringing the position to 7,797 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3531.
Tower Research Capital (TRC) first reported a position in ORGO in Q3 2017 and has held it in 31 quarters since. The position peaked at $362K in Q1 2022. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.
- Tower Research Capital (TRC) held 7,797 shares of Organogenesis Holdings worth $18.5K as of Q1 2026.
- Tower Research Capital (TRC) bought 5,781 Organogenesis Holdings shares in Q1 2026, an estimated $20K.
- Organogenesis Holdings made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3531 holding.
- Tower Research Capital (TRC) first reported a position in Organogenesis Holdings in Q3 2017 and has held it in 31 quarters since.
- Tower Research Capital (TRC)'s Organogenesis Holdings position peaked at $362K in Q1 2022.
- 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.